Hepatocyte Autophagy: Maintaining a Toxic‐Free Environment
Heather Francis, Nan Wu, Gianfranco Alpini, Fanyin Meng – 9 March 2020
Long‐Term Study of Hepatitis Delta Virus Infection at Secondary Care Centers: The Impact of Viremia on Liver‐Related Outcomes
Habiba Kamal, Gabriel Westman, Karolin Falconer, Ann‐Sofi Duberg, Ola Weiland, Susanna Haverinen, Rune Wejstål, Tony Carlsson, Christian Kampmann, Simon B. Larsson, Per Björkman, Anders Nystedt, Kristina Cardell, Stefan Svensson, Stephan Stenmark, Heiner Wedemeyer, Soo Aleman – 7 March 2020
Cadence From Physical Activity Trackers for Monitoring of Home‐Based Exercise Intensity in Advanced Liver Disease
Hui Wei Chen, Arny A. Ferrando, Michael A. Dunn, W. Ray Kim, Andrés Duarte‐Rojo – 7 March 2020
Activation of the Liver X Receptor Pathway Inhibits HBV Replication in Primary Human Hepatocytes
Jing Zeng, Daitze Wu, Hui Hu, John A.T. Young, Zhipeng Yan, Lu Gao – 7 March 2020
Mutations in the V‐ATPase Assembly Factor VMA21 Cause a Congenital Disorder of Glycosylation With Autophagic Liver Disease
Magda Cannata Serio, Laurie A. Graham, Angel Ashikov, Lars Elmann Larsen, Kimiyo Raymond, Sharita Timal, Gwenn Le Meur, Margret Ryan, Elzbieta Czarnowska, Jos C. Jansen, Miao He, Can Ficicioglu, Pavel Pichurin, Linda Hasadsri, Berge Minassian, Alessandra Rugierri, Hannu Kalimo, W. Alfredo Ríos‐Ocampo, Christian Gilissen, Richard Rodenburg, Johan W. Jonker, Adriaan G. Holleboom, Eva Morava, Joris A. Veltman, Piotr Socha, Tom H. Stevens, Matias Simons, Dirk J. Lefeber – 7 March 2020
Synthetic Conjugates of Ursodeoxycholic Acid Inhibit Cystogenesis in Experimental Models of Polycystic Liver Disease
Francisco J. Caballero‐Camino, Ivan Rivilla, Elisa Herraez, Oscar Briz, Alvaro Santos‐Laso, Laura Izquierdo‐Sanchez, Pui Y. Lee‐Law, Pedro M. Rodrigues, Patricia Munoz‐Garrido, Sujeong Jin, Estanislao Peixoto, Seth Richard, Sergio A. Gradilone, Maria J. Perugorria, Manel Esteller, Luis Bujanda, Jose J.G. Marin, Jesus M. Banales, Fernando P. Cossío – 7 March 2020
Transcriptional Dynamics of Hepatic Sinusoid‐Associated Cells After Liver Injury
Mike K. Terkelsen, Sofie M. Bendixen, Daniel Hansen, Emma A.H. Scott, Andreas F. Moeller, Ronni Nielsen, Susanne Mandrup, Anders Schlosser, Thomas L. Andersen, Grith L. Sorensen, Aleksander Krag, Kedar N. Natarajan, Sönke Detlefsen, Henrik Dimke, Kim Ravnskjaer – 7 March 2020
Direct‐Acting Antivirals and Hepatocellular Carcinoma: No Evidence of Higher Wait‐List Progression or Posttransplant Recurrence
Federico Piñero, Ilka Boin, Aline Chagas, Emilio Quiñonez, Sebastián Marciano, Mario Vilatobá, Luisa Santos, Margarita Anders, Sergio Hoyos Duque, Agnaldo Soares Lima, Josemaría Menendez, Martín Padilla, Jaime Poniachik, Rodrigo Zapata, Martín Maraschio, Ricardo Chong Menéndez, Linda Muñoz, Diego Arufe, Rodrigo Figueroa, Manuel Mendizabal, Sahara Hurtado Gomez, Raquel Stucchi, Claudia Maccali, Rodrigo Vergara Sandoval, Carla Bermudez, Lucas McCormack, Adriana Varón, Adrián Gadano, Juan Mattera, Fernando Rubinstein, Flair Carrilho, Marcelo Silva – 4 March 2020 – The association between direc
Autoimmune Hepatitis: Highlights for Liver Transplant Providers From the American Association for the Study of Liver Diseases 2019 Guidelines
Nanda Kerkar, Marlyn J. Mayo – 4 March 2020
Hepatocellular Protein Arginine Methyltransferase 1 Suppresses Alcohol‐Induced Hepatocellular Carcinoma Formation by Inhibition of Inducible Nitric Oxide Synthase
Jie Zhao, Maura O'Neil, Michael Schonfeld, Amberly Komatz, Steven A. Weinman, Irina Tikhanovich – 4 March 2020 – Alcohol is a well‐established risk factor for hepatocellular carcinoma (HCC), but the mechanisms by which alcohol promotes liver cancer are not well understood. Studies suggest that ethanol may enhance tumor progression by increasing hepatocyte proliferation and through alcohol‐induced liver inflammation. Protein arginine methyltransferase 1 (PRMT1) is the main enzyme responsible for cellular arginine methylation.